FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Grail's Galleri blood test shows promise in detecting early-stage cancers, boosting the company's stock, but experts call for more data before broad rollout.
Pacers sign G League standout McClung, waive center Wiseman to address backcourt injuries
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Grail's Galleri blood test shows promise in detecting early-stage cancers, boosting the company's stock, but experts call for more data before broad rollout.
Pacers sign G League standout McClung, waive center Wiseman to address backcourt injuries